Insider Stock Trading History of Digiandomenico Anthony


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Digiandomenico Anthony since year 2005. The trader's CIK number is 1083544. At the time of this reporting, Digiandomenico Anthony is the Director of Cue Biopharma, Inc. . (stock ticker symbol CUE). See this page for all insider trading activities at Cue Biopharma, Inc. .

Note that in the past DIGIANDOMENICO ANTHONY also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Digiandomenico Anthony since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-12-24 CUE Cue Biopharma, Inc. Buy 10,000 4.81 48,099
2018-12-28 CUE Cue Biopharma, Inc. Buy 7,000 4.62 32,340
2018-12-28 PRVB Provention Bio, Inc. Buy 10,000 1.76 17,600
2018-12-27 PRVB Provention Bio, Inc. Buy 20,000 1.95 39,000
2018-12-27 CUE Cue Biopharma, Inc. Buy 20,000 4.77 95,399
2018-12-24 PRVB Provention Bio, Inc. Buy 17,270 1.92 33,158
2018-12-21 PRVB Provention Bio, Inc. Buy 2,000 1.85 3,700
2018-12-21 CUE Cue Biopharma, Inc. Buy 10,000 4.49 44,900
2018-12-20 PRVB Provention Bio, Inc. Buy 5,000 1.96 9,800
2018-12-17 CUE Cue Biopharma, Inc. Buy 10,000 5.48 54,800
2018-12-03 PRVB Provention Bio, Inc. Buy 4,442 2.45 10,882
2018-11-29 PRVB Provention Bio, Inc. Buy 151 2.47 372
2018-11-30 PRVB Provention Bio, Inc. Buy 4,849 2.45 11,880
2018-11-27 PRVB Provention Bio, Inc. Buy 10,000 2.46 24,600
2018-11-26 PRVB Provention Bio, Inc. Buy 10,000 2.65 26,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Digiandomenico Anthony (Director of Cue Biopharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.